Is Nef the elusive cause of HIV-associated hematopoietic dysfunction?

Journal of Clinical Investigation

Volumn 118, Issue 5, 2008, Pages 1622-1625

  Kirchhoff, Frank ^a   Silvestri, Guido ^b,c  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN NEGATIVE FACTOR; STAT5A PROTEIN; STAT5B PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACACA; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

ANIMALS; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HIV INFECTIONS; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PPAR GAMMA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; STAT5 TRANSCRIPTION FACTOR;

EID: 43049120264     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35487     Document Type: Note

References (28)

1. Sodora, D.L., and Silvestri, G. 2008. Immune activation and AIDS pathogenesis. AIDS. 22:439-446.
2. Moses, A., Nelson, J., and Bagby, G.C., Jr. 1998. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood. 91:1479-1495.
3. Marandin, A., et al. 1996. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood. 88:4568-4578.
4. Sloand, E.M., et al. 1997. Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS. 11:1547-1553.
5. Isgrò, A., et al. 2000. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses. 16:1471-1479.
6. Baillou, C., et al. 2003. Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy. AIDS. 17:563-574.
7. Koka, P.S., Jamieson, B.D., Brooks, D.G., and Zack, J.A. 1999. Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J. Virol. 73:9089-9097.
8. Weichold, F.F., et al. 1998. Neither human immunodeficiency virus-1 (HIV-1) nor HIV-2 infects most-primitive human hematopoietic stem cells as assessed in long-term bone marrow cultures. Blood. 91:907-915.
9. Zhang, J., Scadden, D.T., and Crumpacker, C.S. 2007. Primitive hematopoietic cells resist HIV-1 infection via p21. J. Clin. Invest. 117:473-481.
10. Calenda, V., Graber, P., Delamarter, J.F., and Chermann, J.C. 1994. Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells. Eur. J. Haematol. 52:103-107.
11. Reinhold, D., Wrenger, S., Kahne, T., and Ansorge, S. 1999. HIV-1 Tat: immunosuppression via TGF-beta1 induction. Immunol. Today. 20:384-385.
12. Sugiura, K., Oyaizu, N., Pahwa, R., Kalyanaraman, V.S., and Pahwa, S. 1992. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood. 80:1463-1469.
13. Maciejewski, J.P., Weichold, F.F., and Young, N.S. 1994. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J. Immunol. 153:4303-4310.
14. Prost, S., et al. 2008. Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques. J. Clin. Invest. 118:1765-1775.
15. Bunting, K.D. 2007. STAT5 signaling in normal and pathologic hematopoiesis. Front. Biosci. 12:2807-2820.
16. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 98:181-191.
17. Cui, Y., et al. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol. Cell. Biol. 24:8037-8047.
18. Foster, J.L., and Garcia, J.V. 2007. Role of Nef in HIV-1 replication and pathogenesis. Adv. Pharmacol. 55:389-409.
19. Schindler, M., et al. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell. 125:1055-1067.
20. Renkema, G.H., and Saksela, K. 2000. Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5:D268-D283.
21. Fujii, Y., Otake, K., Tashiro, M., and Adachi, A. 1996. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 393:93-96.
22. Federico, M., et al. 2001. HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood. 98:2752-2761.
23. Okada, H., Takei, R., and Tashiro, M. 1997. HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas). FEBS Lett. 414:603-606.
24. Qiao, X., et al. 2006. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7:302-310.
25. Cheingsong-Popov, R. 1990. Antibodies to HIV-1 nef (p27): prevalence, significant and relationship to seroconversion. AIDS Res. Hum. Retroviruses. 6:1099-1105.
26. Silvestri, G., Paiardini, M., Pandrea, I., Lederman, M.M., and Sodora, D.L. 2007. Understanding the benign nature of SIV infection in natural hosts. J. Clin. Invest. 117:3148-3154.
27. Burchill, M.A, Yang, J., Vang, K.B., and Farrar, M.A. 2007. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 114:1-8.
28. Ye, P., Kirschner, D.E., and Kourtis, A.P. 2004. The thymus during HIV disease: role in pathogenesis and in immune recovery. Curr. HIV Res. 2:177-183.